Showing results (831-840 of 1,341) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|March 13, 2026
Focused ultrasound for blood-brain barrier opening in brain tumor patients: Technical nuancesMassimiliano Del Bene, Valentina Caldiera, Mario Stanziano, et al.
Neuro-Oncology Advances|March 9, 2026
BRAF-mutant high-grade glioma with pleomorphic and pseudopapillary features (HPAP): A PLNTY mimic demonstrating tumor progression during longitudinal follow-upYutaro Takayama, Mariko Yaegashi, Kaishi Satomi, et al.
Neuro-Oncology Advances|March 9, 2026
Artificial intelligence pipeline predicts the integrated molecular-morphologic risk score of meningiomas from routine preoperative MRIDamjan Veljanoski, Ali Golbaf, Prutha Chawda, et al.
Neuro-Oncology Advances|February 24, 2026
Retrograde longitudinal imaging analyses of IDH-wildtype glioblastoma reveal its clinical timeline from radiological birth to deathRyota Shigeeda, Ichiyo Shibahara, Yasushi Orihashi, et al.
Neuro-Oncology Advances|March 18, 2026
Antiepileptic drugs in glioblastoma survival: dichotomic or treatment and mechanism of action-dependent variable?Oktay Genel, Sultan Alzarouni, Asfand Baig Mirza, et al.
Neuro-Oncology Advances|March 16, 2026
Epigenetic buffering of proteotoxic stress by EHMT2 enables meningioma growthBethany C Berry, Tomas Rodriguez, Connie C Hou, et al.
Neuro-Oncology Advances|February 27, 2026
High human cytomegalovirus antigen expression in pediatric medulloblastoma tissue is associated with poor event-free survivalMaria F De la Cerda-Vargas, Jens Schittenhelm, Martin Ebinger, et al.
Neuro-Oncology Advances|February 2, 2023
Growth dynamics of brain metastases differentiate radiation necrosis from recurrenceBeatriz Ocaña-Tienda, Julián Pérez-Beteta, David Molina-García, et al.
Neuro-Oncology Advances|March 23, 2023
Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients' relativesEljas Alanen, Sanna Heikkinen, Riikka Nurminen, et al.
Neuro-Oncology Advances|February 16, 2026
Enhanced glioblastoma immunotherapy via SMAC mimetic dose escalation and TGFβ blockadeKyle Malone, Melanie Dugas, Nathalie Earl, et al.
Pageof 135